Bookmark

Add to MyYahoo RSS

ImmunoGen News

News on ImmunoGen (Ticker: IMGN) continually updated from thousands of sources around the net.

Monday Jun 16 | Hispanic Business

ImmunoGen, Inc. Announces Preclinical Findings for IMGN779, a...

The data were presented at the 19th . IMGN779 is a novel, CD33-targeting, DNA-alkylating ADC that is a potential treatment for acute myeloid leukemia .

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

Sat Jun 14, 2014

Boston.com

Game changers ImmunoGen's breast cancer therapy took time

Patients and doctors applauded last year when the powerful new breast cancer therapy Kadcyla made its market debut, following a long and winding journey to approval for what many view as a miracle medicine.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

Thu Jun 12, 2014

AmericanBankingNews.com

Immunogen Receives Consensus Rating of "Buy" from Brokerages

Immunogen has earned an average rating of "Buy" from the thirteen brokerages that are presently covering the stock, Analyst Ratings News reports .

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

Sun Jun 01, 2014

Hispanic Business

ImmunoGen, Inc. Announces Favorable STARLYTE Phase II Clinical Data...

The study results were reported in an oral abstract session at the ; they were also selected for Best of ASCO .

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

Freshnews

ImmunoGen, Inc. Announces Favorable STARLYTE Phase II Clinical Data...

ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced the presentation of favorable clinical findings with SAR3419 from the STARLYTE Phase II trial in diffuse large B-cell lymphoma .

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry, Transportation, ASCO plc, Logistics

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••